Fulcrum Therapeutics, Inc. (FULC)
3.46
-0.05
(-1.42%)
USD |
NASDAQ |
Jun 11, 10:55
Fulcrum Therapeutics EPS Diluted (Quarterly) : -0.2479 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.2479 |
| December 31, 2025 | -0.3091 |
| September 30, 2025 | -0.313 |
| June 30, 2025 | -0.2765 |
| March 31, 2025 | -0.2826 |
| December 31, 2024 | -0.3071 |
| September 30, 2024 | -0.3476 |
| June 30, 2024 | 0.8714 |
| March 31, 2024 | -0.4335 |
| December 31, 2023 | -0.4001 |
| September 30, 2023 | -0.3885 |
| June 30, 2023 | -0.3849 |
| March 31, 2023 | -0.4149 |
| December 31, 2022 | -0.5018 |
| September 30, 2022 | -0.5137 |
| June 30, 2022 | -0.8332 |
| March 31, 2022 | -0.6379 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.5787 |
| September 30, 2021 | -0.5659 |
| June 30, 2021 | -0.602 |
| March 31, 2021 | -0.5395 |
| December 31, 2020 | -0.6435 |
| September 30, 2020 | -0.6956 |
| June 30, 2020 | -0.6575 |
| March 31, 2020 | -0.8122 |
| December 31, 2019 | -0.7131 |
| September 30, 2019 | -0.9749 |
| June 30, 2019 | -0.7052 |
| March 31, 2019 | -1.709 |
| December 31, 2018 | -0.4597 |
| September 30, 2018 | -0.4788 |
| June 30, 2018 | -0.3811 |
| March 31, 2018 | -0.3328 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.1668 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -0.90 |
| Definium Therapeutics, Inc. | -0.7087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.89M |
| Total Expenses (Quarterly) | 18.89M |
| Enterprise Value | -93.65M |
| Earnings Yield | -33.14% |
| Normalized Earnings Yield | -33.14 |